This partnership is poised to revolutionize clinical insights and decision-making for the pharma industry with the aim of enhancing therapeutic efficacy and commercial lifespan.
Constructed using low-drug-absorbing plastics, Chip-R1 builds upon the core microfluidic design of Organ-Chips, offering researchers greater precision in predicting human drug responses.
In this webinar, Junguk Park and Vanda Lopes will discuss luciferase-based reporter cell lines that assess cytokine signaling, GPCR signaling, and enzyme activity.